Prostate Cancer Clinical Trials in Houston

Showing 141-160 of 171 trials

Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer

NCT01076335

The goal of this clinical research study is to find out if a therapy using docetaxel chemotherapy with hormonal therapy taken before your scheduled surgery is beneficial to treatment of prostate cancer. The safety of this combination will also be studied.

Prostate Cancer

M.D. Anderson Cancer Center40 participantsStarted May 2005

Houston, Texas, United States

TERMINATEDPHASE3< 1 mile

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

NCT00024167

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radioactive substances such as strontium-89 may relieve bone pain associated with prostate cancer. It is not yet known whether chemotherapy is more effective with or without strontium-89 in treating bone metastases. PURPOSE: This randomized phase III trial is studying giving chemotherapy together with strontium-89 to see how well it works compared to chemotherapy alone in treating patients with prostate cancer that has spread to the bone.

Prostate Cancer

M.D. Anderson Cancer Center265 participantsStarted Apr 2002

Gainesville, Georgia, United States • Savannah, Georgia, United States • Hines, Illinois, United States +37 more locations

Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Prostate Cancer Trials in Other Cities

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer

AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC)

Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer

Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancer

Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008

Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling

The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

3-AP in Treating Patients With Advanced Prostate Cancer

Multi-site Decision Impact Study for Decipher

Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Other Conditions in Houston